Eli Lilly and Co
LLY
1,240.34
-16.69
-1.33%
Eli Lilly and Co
US · LLY
#17 by market cap
Listed 1970
1,240.34
-16.69
-1.33%
Live - 5344 symbols - heartbeat 9s ago
· 2026-10-20 06:27
Analyst consensus 22 analysts
Buy
Avg price target 1,383.47 +11.5%
Price target rangecurrent 1,240.34
Low940.00
Avg1,383.47
High1,600.00
Buy 91%
Hold 5%
Sell 5%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-09 | BofA Securities | -- | Buy | 1,341.00 |
| 2026-10-09 | Morgan Stanley | -- | Buy | 1,430.00 |
| 2026-10-09 | J.P. Morgan | -- | Buy | 1,500.00 |
| 2026-10-08 | Cantor Fitzgerald | -- | Buy | 1,440.00 |
| 2026-10-07 | Morgan Stanley | -- | Buy | 1,430.00 |
| 2026-10-05 | Barclays | -- | Buy | 1,400.00 |
| 2026-10-01 | TD Cowen | -- | Buy | 1,250.00 |
| 2026-10-01 | Truist Financial | -- | Buy | -- |
| 2026-10-01 | RBC Capital | -- | Buy | 1,500.00 |
| 2026-09-30 | BMO Capital | -- | Buy | 1,400.00 |
| 2026-09-30 | Goldman Sachs | -- | Buy | 1,371.00 |
| 2026-09-28 | Barclays | -- | Buy | 1,400.00 |
| 2026-09-28 | J.P. Morgan | -- | Buy | 1,500.00 |
| 2026-09-23 | Evercore | -- | Hold | -- |
| 2026-09-22 | TD Cowen | -- | Buy | 1,250.00 |
| 2026-09-22 | Jefferies | -- | Buy | 1,440.00 |
| 2026-09-21 | Wells Fargo | -- | Buy | 1,330.00 |
| 2026-09-21 | Barclays | -- | Buy | 1,400.00 |
| 2026-09-21 | RBC Capital | -- | Buy | 1,500.00 |
| 2026-09-17 | Guggenheim | -- | Buy | 1,284.00 |
| 2026-09-16 | Leerink Partners | -- | Buy | -- |
| 2026-09-14 | Berenberg Bank | -- | Buy | 1,400.00 |
| 2026-09-14 | RBC Capital | -- | Buy | 1,500.00 |
| 2026-09-10 | HSBC | -- | Sell | 940.00 |
| 2026-09-08 | Barclays | -- | Buy | 1,400.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
2 1
■ Upgrades■ Downgrades
- 2 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Berenberg Bank moved from Hold to Buy on 2026-09-14.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-14 | Berenberg Bank | Hold → Buy | 1,400.00 |
| 2026-03-17 | HSBC | Hold → Sell | 850.00 |
| 2025-11-10 | Leerink Partners | Hold → Buy | 1,104.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-29 | -- | -- | -- |
| 2026/Q2 | 2026-08-05 | -- | ±7.18% | +4.86% (in line) |
| 2026/Q1 | 2026-04-30 | -- | ±6.06% | +9.80% (beat) |
| 2025/Q4 | 2026-02-04 | -- | ±6.97% | +10.33% (beat) |
| 2025/Q3 | 2025-10-30 | -- | ±5.34% | +3.81% (in line) |
| 2025/Q2 | 2025-08-07 | -- | ±6.58% | -14.14% (beat) |
| 2025/Q1 | 2025-05-01 | -- | ±5.16% | -11.66% (beat) |
| 2024/Q4 | 2025-02-06 | -- | ±5.28% | +3.35% (in line) |
| 2024/Q3 | 2024-10-30 | -- | ±6.04% | -6.28% (beat) |
| 2024/Q2 | 2024-08-08 | -- | ±7.23% | +9.48% (beat) |
| 2024/Q1 | 2024-04-30 | -- | ±5.59% | +5.96% (beat) |
| 2023/Q4 | 2024-02-06 | -- | ±6.42% | -0.17% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-20 06:27:52 · For reference only, not investment advice and not tailored to your situation.
the GLP-1 demand curve still doesn’t look like it’s topping, manufacturing capacity is the actual bottleneck here not demand, which is a good problem to have.